Zevra Therapeutics Inc. (ZVRA) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Zevra Therapeutics Inc.

    NASDAQ: ZVRA · Real-Time Price · USD
    9.75
    0.44 (4.73%)
    At close: Oct 03, 2025, 3:59 PM
    9.81
    0.62%
    Pre-market: Oct 06, 2025, 05:23 AM EDT

    Zevra Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -3.66 -5.04 -5.91 -30.31
    PEG Ratio
    		 -0.05 -0.08 0.09 0.88
    PS Ratio
    		 16.34 8.46 15.58 9.05
    PB Ratio
    		 9.72 3.75 2.11 2.04
    P/FCF Ratio
    		 -5.54 -6.86 -8.42 25.08
    P/OCF Ratio
    		 -5.54 -6.92 -8.46 24.84
    OCF/S Ratio
    		 -2.95 -1.22 -1.84 0.36
    Debt / Equity Ratio
    		 1.52 0.71 0.19 0.01
    Quick Ratio
    		 2.47 0.85 7.74 27.20
    Current Ratio
    		 2.53 1.18 7.74 27.20
    Asset Turnover
    		 0.13 0.16 0.09 0.22
    Interest Coverage
    		 -11.84 -33.05 -127.06 20.56
    Return on Equity
    		 -2.66 -0.74 -0.36 -0.07
    Return on Assets
    		 -0.59 -0.27 -0.23 -0.06
    Return on Invested Capital
    		 -0.7 -0.36 -0.41 0.06
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.69 0.89 0.98 0.93
    Net Profit Margin
    		 -4.47 -1.68 -2.63 -0.3
    Pretax Profit Margin
    		 -3.82 -1.68 -2.64 -0.3
    Operating Profit Margin
    		 -3.68 -1.81 -4.19 0.27
    FCF Margin
    		 -2.95 -1.23 -1.85 0.36
    EBITDA Margin
    		 -3.24 -1.59 -2.51 -0.28

    Add to Watchlist